US › Healthcare

Cardio Diagnostics Holdings Inc (CDIO)

US · Healthcare · Biotechnology

$1.74+6.10%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2,680

Revenue YoY

+185.1%

Net profit

$-1.8M

Profit YoY

-9.4%

EPS

$-0.63

Net margin

-66,722.3%

Key statistics

Market cap

$4.6M

Forward P/E

0.0

P/B

0.53

Book value

$3.01

EPS (TTM)

$-3.37

52-week high

$7.91

52-week low

$0.97

50-day MA

$1.86

200-day MA

$2.54

Beta

2.18

Analyst view

Analysts rate Cardio Diagnostics Holdings Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $60.00.

Shareholding

Insiders

8.31%

Institutions

9.34%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	2.75%
HRT FINANCIAL LLC	2.11%
BlackRock Inc	1.17%
Geode Capital Management, LLC	1.09%
Vanguard Capital Management, LLC	0.68%
Renaissance Technologies Corp	0.52%
Scientech Research LLC	0.47%
UBS Group AG	0.34%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cardio Diagnostics Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.